Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Lupin, YL Biologics receive nod to market rheumatoid arthritis drug in Japan

expressbpdMarch 27, 2019

Tag: lupin , Rheumatoid Arthritis , Japan , YL Biologics , biosimilar

PharmaSources Customer Service